Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-1209 in hypercholesterolemia on statin therapy
CTR20190921Phase 2Completed
- Sponsor
- Suzhou Sundia Biotech Co., Ltd.
- Start
- May 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of recaticimab in hypercholesterolemia, sponsored by Suzhou Sundia Biotech Co., Ltd.. Started May 2019; status: completed.
02
Drugs
recaticimab
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on CTR20190921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190921.